【制药网 行业动态】8月7日,医药行业传来一系列振奋人心的消息,海思科、中国生物制药、百奥泰、普洛药业、复宏汉霖等多家药企集中披露了创新药临床试验的新进展。这一波密集的研发动态不仅展现了国内药企在创新药领域的强劲实力,更为广大患者带来了新的治疗希望,也彰显了我国医药行业在创新驱动发展道路上的坚实步伐。其中,海思科公告,公司自主研发的创新药HSK47388片获国家药品监督管理局批准开展临床试验。该...
Source Link【制药网 行业动态】8月7日,医药行业传来一系列振奋人心的消息,海思科、中国生物制药、百奥泰、普洛药业、复宏汉霖等多家药企集中披露了创新药临床试验的新进展。这一波密集的研发动态不仅展现了国内药企在创新药领域的强劲实力,更为广大患者带来了新的治疗希望,也彰显了我国医药行业在创新驱动发展道路上的坚实步伐。其中,海思科公告,公司自主研发的创新药HSK47388片获国家药品监督管理局批准开展临床试验。该...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.